Closing the Gaps to Timely Patient Access: Perspectives on Conditional Funding Models

The Canadian system for approval of new cancer drugs is complex with multiple steps. Health Canada grants a license for a drug to be marketed and prescribed. The Canadian Agency for Drugs and Technologies in Health (CADTH) and Institut national d’excellence en santé et services sociaux (INESSS) make...

Descripción completa

Detalles Bibliográficos
Autores principales: Glennie, Judith, Villalba, Eva, Wheatley-Price, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870899/
https://www.ncbi.nlm.nih.gov/pubmed/35200582
http://dx.doi.org/10.3390/curroncol29020083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870899/
https://www.ncbi.nlm.nih.gov/pubmed/35200582
http://dx.doi.org/10.3390/curroncol29020083

Ejemplares similares